Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

PIPERACILLIN SODIUM & TAZOBACTAM SODIUM

All injection strengths: not a benefit

Other products in the same Health Canada class (J01C, J01CR) — coverage varies; not interchangeable

  • Amoxicillin + clavulanic acid (Clavulin): general benefit, Not a benefit
  • Amoxicillin (Novamoxin): general benefit, Not a benefit, Listing status unconfirmed
  • Ampicillin (Penbritin): general benefit, Not a benefit
  • Cloxacillin (Orbenin): general benefit, Not a benefit
  • Penicillin v (Nadopen-V): general benefit, Not a benefit

Piperacillin & Tazobactam For Injection · DIN 02402068 · 2g & 250mg · injection Pd-2.25g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402068 Manufacturer: Auro Pharma Inc.; listing date 2021-08-31 Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam For Injection: Formulary list price $10.1300/unit (unit not stated in source; not the patient's cost)

Ministry pays: $10.1300 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88693 · Verify on the e-Formulary ↗ (DIN 02402068)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402068). DIN 02402068: Piperacillin & Tazobactam For Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id AUR Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $10.1300; ministry $10.1300 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02402068 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88693
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300 Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300 Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended 2025-02-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02402068
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam for Injection · DIN 02362619 · 2g & 250mg · injection Pd-2.25g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362619 Manufacturer: Sterimax Inc.; listing date 2016-06-29 Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 2.00 G/VIAL · company Sterimax inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $10.1300/unit (unit not stated in source; not the patient's cost)

Ministry pays: $10.1300 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84762 · Verify on the e-Formulary ↗ (DIN 02362619)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362619). DIN 02362619: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id STE Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $10.1300; ministry $10.1300 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02362619 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84762
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300 Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300 Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended 2024-11-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02362619
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam For Injection · DIN 02402076 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402076 Manufacturer: Auro Pharma Inc.; listing date 2021-08-31 Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam For Injection: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88694 · Verify on the e-Formulary ↗ (DIN 02402076)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402076). DIN 02402076: Piperacillin & Tazobactam For Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id AUR Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02402076 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88694
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended 2025-02-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02402076
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam for Injection · DIN 02362627 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362627 Manufacturer: Sterimax Inc.; listing date 2016-06-29 Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3.000 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Sterimax inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84763 · Verify on the e-Formulary ↗ (DIN 02362627)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362627). DIN 02362627: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id STE Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02362627 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84763
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended 2024-09-13); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02362627
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam For Injection · DIN 02402084 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam For Injection · DIN 02402084 Manufacturer: Auro Pharma Inc.; listing date 2021-08-31 Health Canada: Marketed since 2021-06-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam For Injection: Formulary list price $20.2700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $20.2700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88695 · Verify on the e-Formulary ↗ (DIN 02402084)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02402084). DIN 02402084: Piperacillin & Tazobactam For Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id AUR Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $20.2700; ministry $20.2700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02402084 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88695
Interchangeable products
Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700 Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700 Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700 Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended 2025-02-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02402084
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam for Injection · DIN 02362635 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02362635 Manufacturer: Sterimax Inc.; listing date 2016-06-29 Health Canada: Marketed since 2011-08-29 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL · company Sterimax inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $20.2700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $20.2700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84764 · Verify on the e-Formulary ↗ (DIN 02362635)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02362635). DIN 02362635: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id STE Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $20.2700; ministry $20.2700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02362635 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84764
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700 Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700 Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700 Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended 2024-09-13); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02362635
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Piperacillin & Tazobactam for Injection · DIN 02308444 · 2g & 250mg · injection Pd-2.25g vial

Off-Formulary Interchangeable, not an ODB benefitDormant since 2018-08-03 · checked 2026-09-02 · What does dormant mean?
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308444 Manufacturer: Apotex Inc.; listing date 2008-12-03 Health Canada: Dormant since 2018-08-03 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $10.1300/unit (unit not stated in source; not the patient's cost)

Ministry pays: $10.1300 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79408 · Verify on the e-Formulary ↗ (DIN 02308444)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308444). DIN 02308444: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id APX Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $10.1300; ministry $10.1300 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02308444 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79408
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300 Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300 Tazocin · DIN 02170817 · not recorded
Shortage status: active shortage (reported 2014-10-01, last updated 2018-09-12) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308444
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2018-08-03 — choose a marketed DIN from the same-category list.

Piperacillin & Tazobactam for Injection · DIN 02308452 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefitDormant since 2017-08-04 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308452 Manufacturer: Apotex Inc.; listing date 2008-12-03 Health Canada: Dormant since 2017-08-04 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3.0 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79409 · Verify on the e-Formulary ↗ (DIN 02308452)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308452). DIN 02308452: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id APX Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02308452 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79409
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: active shortage (reported 2016-09-07, last updated 2018-09-12) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308452
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2017-08-04 — choose a marketed DIN from the same-category list.

Piperacillin & Tazobactam for Injection · DIN 02308460 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefitDormant since 2017-08-04 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02308460 Manufacturer: Apotex Inc.; listing date 2008-12-03 Health Canada: Dormant since 2017-08-04 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G/VIAL · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $20.2700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $20.2700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79410 · Verify on the e-Formulary ↗ (DIN 02308460)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02308460). DIN 02308460: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id APX Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $20.2700; ministry $20.2700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02308460 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79410
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700 Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700 Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700 Tazocin · DIN 02170809 · not recorded
Shortage status: active shortage (reported 2016-09-07, last updated 2017-10-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308460
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2017-08-04 — choose a marketed DIN from the same-category list.

Piperacillin and Tazobactam for Inj · DIN 02401312 · 2g & 250mg · injection Pd-2.25g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.Discontinued 2023-01-01 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401312 Manufacturer: Teligent OU; listing date 2018-11-29 Health Canada: Cancelled post market since 2023-01-01 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL · company Hikma canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin and Tazobactam for Inj: Formulary list price $10.1300/unit (unit not stated in source; not the patient's cost)

Ministry pays: $10.1300 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88623 · Verify on the e-Formulary ↗ (DIN 02401312)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401312). DIN 02401312: Piperacillin and Tazobactam for Inj Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id TEL Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $10.1300; ministry $10.1300 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401312 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88623
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300 Tazocin · DIN 02170817 · not recorded
Shortage status: resolved shortage (ended 2022-07-21); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02401312
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2023-01-01 — choose a marketed DIN from the same-category list.

Tazocin · DIN 02170817 · 2g & 250mg · injection Pd-2.25g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.Discontinued 2015-04-27 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Tazocin · DIN 02170817 Manufacturer: Pfizer Canada Inc.; listing date 2008-12-03 Health Canada: Cancelled post market since 2015-04-27 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 2 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 250 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Check this DIN again · Health Canada product record

Tazocin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44170 · Verify on the e-Formulary ↗ (DIN 02170817)

Source record
DIN 02170817: Tazocin Raw flags: sec3=Y, sec3b=Y Item: 081216101; group id 30; item number 0062; lccId None; manufacturer id PFI Source form: Inj Pd-2.25g Vial Pk; strength: 2g & 250mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02170817 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44170
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402068 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02308444 · $10.1300 Piperacillin & Tazobactam for Injection · DIN 02362619 · $10.1300 Piperacillin and Tazobactam for Inj · DIN 02401312 · $10.1300
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02170817
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.

Piperacillin & Tazobactam for Injection · DIN 02391538 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.Discontinued 2016-07-06 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin & Tazobactam for Injection · DIN 02391538 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2012-12-21 Health Canada: Cancelled post market since 2016-07-06 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL · company Mylan pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin & Tazobactam for Injection: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87686 · Verify on the e-Formulary ↗ (DIN 02391538)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02391538). DIN 02391538: Piperacillin & Tazobactam for Injection Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id MYL Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02391538 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=87686
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02391538
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2016-07-06 — choose a marketed DIN from the same-category list.

Piperacillin and Tazobactam for Inj · DIN 02401320 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.Discontinued 2022-09-09 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401320 Manufacturer: Teligent OU; listing date 2018-11-29 Health Canada: Cancelled post market since 2022-09-09 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Hikma canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin and Tazobactam for Inj: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88624 · Verify on the e-Formulary ↗ (DIN 02401320)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401320). DIN 02401320: Piperacillin and Tazobactam for Inj Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id TEL Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401320 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88624
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: resolved shortage (ended 2022-07-21); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02401320
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2022-09-09 — choose a marketed DIN from the same-category list.

Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.Discontinued 2019-11-18 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin/Tazobactam powder for Inj. · DIN 02370166 Manufacturer: Teva Canada Limited; listing date 2012-07-27 Health Canada: Cancelled post market since 2019-11-18 · brand PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G/VIAL · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin/Tazobactam powder for Inj.: Formulary list price $15.2000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.2000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85518 · Verify on the e-Formulary ↗ (DIN 02370166)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02370166). DIN 02370166: Piperacillin/Tazobactam powder for Inj. Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id TEV Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $15.2000; ministry $15.2000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02370166 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85518
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Tazocin · DIN 02170795 · not recorded
Shortage status: discontinued (2022-03-30, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02370166
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2019-11-18 — choose a marketed DIN from the same-category list.

Tazocin · DIN 02170795 · 3g & 375mg · injection Pd-3.375g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.Discontinued 2015-02-26 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Tazocin · DIN 02170795 Manufacturer: Wyeth Ltd.; listing date 2008-12-03 Health Canada: Cancelled post market since 2015-02-26 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 3 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 375 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Check this DIN again · Health Canada product record

Tazocin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44168 · Verify on the e-Formulary ↗ (DIN 02170795)

Source record
DIN 02170795: Tazocin Raw flags: sec3=Y, sec3b=Y Item: 081216097; group id 30; item number 0063; lccId None; manufacturer id WYE Source form: Inj Pd-3.375g Vial Pk; strength: 3g & 375mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02170795 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44168
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402076 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02308452 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02362627 · $15.2000 Piperacillin & Tazobactam for Injection · DIN 02391538 · $15.2000 Piperacillin and Tazobactam for Inj · DIN 02401320 · $15.2000 Piperacillin/Tazobactam powder for Inj. · DIN 02370166 · $15.2000
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02170795
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2015-02-26 — choose a marketed DIN from the same-category list.

Piperacillin and Tazobactam for Inj · DIN 02401339 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.Discontinued 2022-06-02 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin and Tazobactam for Inj · DIN 02401339 Manufacturer: Teligent OU; listing date 2018-11-29 Health Canada: Cancelled post market since 2022-06-02 · brand PIPERACILLIN AND TAZOBACTAM FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL · company Hikma canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin and Tazobactam for Inj: Formulary list price $20.2700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $20.2700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88625 · Verify on the e-Formulary ↗ (DIN 02401339)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02401339). DIN 02401339: Piperacillin and Tazobactam for Inj Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id TEL Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $20.2700; ministry $20.2700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02401339 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88625
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700 Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700 Tazocin · DIN 02170809 · not recorded
Shortage status: resolved shortage (ended 2022-07-21); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02401339
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2022-06-02 — choose a marketed DIN from the same-category list.

Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.Discontinued 2018-02-20 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Piperacillin/Tazobactam powder for Inj. · DIN 02370174 Manufacturer: Teva Canada Limited; listing date 2012-07-27 Health Canada: Cancelled post market since 2018-02-20 · brand PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G/VIAL, PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Piperacillin/Tazobactam powder for Inj.: Formulary list price $20.2700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $20.2700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85519 · Verify on the e-Formulary ↗ (DIN 02370174)

Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02370174). DIN 02370174: Piperacillin/Tazobactam powder for Inj. Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id TEV Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed) Source prices (unrounded): $20.2700; ministry $20.2700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02370174 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85519
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700 Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700 Tazocin · DIN 02170809 · not recorded
Shortage status: discontinued (2022-03-30, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02370174
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2018-02-20 — choose a marketed DIN from the same-category list.

Tazocin · DIN 02170809 · 4g & 500mg · injection Pd-4.5g vial

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.Discontinued 2015-04-27 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Tazocin · DIN 02170809 Manufacturer: Wyeth Ltd.; listing date 2008-12-03 Health Canada: Cancelled post market since 2015-04-27 · brand TAZOCIN · ATC J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR · form Powder for solution · route Intravenous · ingredients PIPERACILLIN (PIPERACILLIN SODIUM) 4 G/VIAL, TAZOBACTAM (TAZOBACTAM SODIUM) 500 MG/VIAL · company Pfizer canada ulc · schedule Prescription
Check this DIN again · Health Canada product record

Tazocin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44169 · Verify on the e-Formulary ↗ (DIN 02170809)

Source record
DIN 02170809: Tazocin Raw flags: sec3=Y, sec3b=Y Item: 081216102; group id 30; item number 0064; lccId None; manufacturer id WYE Source form: Inj Pd-4.5g Vial Pk; strength: 4g & 500mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02170809 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=44169
Interchangeable products
Piperacillin & Tazobactam For Injection · DIN 02402084 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02308460 · $20.2700 Piperacillin & Tazobactam for Injection · DIN 02362635 · $20.2700 Piperacillin and Tazobactam for Inj · DIN 02401339 · $20.2700 Piperacillin/Tazobactam powder for Inj. · DIN 02370174 · $20.2700
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02170809
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2015-04-27 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (08:12:16 Penicillins) and how they are covered

Matched class: 08:12:16 Penicillins

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): AMOXICILLIN, AMOXICILLIN & CLAVULANIC ACID, AMPICILLIN, CLOXACILLIN, PENICILLIN V (POTASSIUM) 08:12:16 Penicillins

AMOXICILLIN & CLAVULANIC ACID

· 25 products · General benefit (22), Listed, not a benefit (3) · strengths: 25mg & 6.25mg/mL, 50mg & 12.5mg/mL, 200mg & 28.5mg/5mL, 400mg & 57mg/5mL, 250mg & 125mg, 500mg & 125mg, 875mg & 125mg · O/L, Susp, Tab

AMOXICILLIN

· 36 products · General benefit (27), Listed, not a benefit (4), Off-Formulary Interchangeable, not an ODB benefit (4), Temporary benefit (1) · strengths: 250mg, 500mg, 125mg, 25mg/mL, 50mg/mL · Cap, Chew Tab, O/L, Pd for Oral Susp

AMPICILLIN

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 250mg, 500mg · Cap

CLOXACILLIN

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 250mg, 500mg, 25mg/mL · Cap, O/L

PENICILLIN V (POTASSIUM)

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 25mg/mL, 300mg · O/L, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:16
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Piperacillin and Tazobactam for Injection (sterile piperacillin sodium / tazobactam sodium) is indicated for the treatment of patients with systemic and / or local bacterial infections, caused by piperacillin resistant, piperacillin / tazobactam susceptible, ß-lactamase producing strains of the designated microorganisms in the specified conditions listed below: a) INTRA-ABDOMINAL INFECTIONS Appendicitis (complicated by rupture or abscess) and peritonitis caused by piperacillin resistant, ß-lactamase producing strains of Escherichia coli or members of the Bacteroides fragilis group. b) SKIN AND SKIN STRUCTURE INFECTIONS Uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscess, acute ischemic / diabetic foot infections caused by piperacillin resistant ß-lactamase producing strains of Staphylococcus aureus (not methicillin-resistant strains). c) GYNECOLOGICAL INFECTIONS Postpartum endometritis or pelvic inflammatory disease caused by piperacillin resistant, ß - lactamase producing strains of Escherichia coli. d) COMMUNITY-ACQUIRED LOWER RESPIRATORY TRACT INFECTIONS… https://pdf.hres.ca/dpd_pm/00078136.PDF PM date: DEC 24, 2024 Source product: PIPERACILLIN AND TAZOBACTAM FOR INJECTION; DIN 02362619; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Piperacillin & Tazobactam for Injection · DIN 02308444 Shortage status: active shortage (reported 2014-10-01, last updated 2018-09-12) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308444

Check this DIN again

Piperacillin & Tazobactam for Injection · DIN 02308452 Shortage status: active shortage (reported 2016-09-07, last updated 2018-09-12) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308452

Check this DIN again

Piperacillin & Tazobactam for Injection · DIN 02308460 Shortage status: active shortage (reported 2016-09-07, last updated 2017-10-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02308460

Check this DIN again

Piperacillin/Tazobactam powder for Inj. · DIN 02370166 Shortage status: discontinued (2022-03-30, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02370166

Check this DIN again

Piperacillin/Tazobactam powder for Inj. · DIN 02370174 Shortage status: discontinued (2022-03-30, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02370174

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Piperacillin & Tazobactam For Injection, Piperacillin & Tazobactam for Injection, Piperacillin and Tazobactam for Inj, Tazocin, Piperacillin/Tazobactam powder for Inj.: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026